280 related articles for article (PubMed ID: 27770715)
1. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
3. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
[TBL] [Abstract][Full Text] [Related]
4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
5. High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection.
Zhang Y; Xu H; Chi X; Fan Y; Shi Y; Niu J
Medicine (Baltimore); 2018 Aug; 97(35):e11781. PubMed ID: 30170372
[TBL] [Abstract][Full Text] [Related]
6. Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma.
Estevez J; Chen VL; Podlaha O; Li B; Le A; Vutien P; Chang ET; Rosenberg-Hasson Y; Jiang Z; Pflanz S; Ge D; Gaggar A; Nguyen MH
Sci Rep; 2017 Sep; 7(1):11867. PubMed ID: 28928388
[TBL] [Abstract][Full Text] [Related]
7. The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma.
El-Daly UM; Saber MM; Abdellateif MS; Nassar HR; Namour AE; Ismail YM; Zekri AN
Asian Pac J Cancer Prev; 2020 Mar; 21(3):599-609. PubMed ID: 32212784
[TBL] [Abstract][Full Text] [Related]
8. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.
Hsu CS; Liu WL; Chao YC; Lin HH; Tseng TC; Wang CC; Chen DS; Kao JH
Hepatol Int; 2015 Apr; 9(2):231-42. PubMed ID: 25788201
[TBL] [Abstract][Full Text] [Related]
10. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
[TBL] [Abstract][Full Text] [Related]
11. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
13. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
14. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
15. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index.
Nartey YA; Awuku YA; Agyei-Nkansah A; Duah A; Bampoh SA; Ayawin J; Asibey SO; Björkström NK; Ye W; Afihene MY; Roberts LR; Plymoth A
BMC Gastroenterol; 2020 Dec; 20(1):428. PubMed ID: 33357229
[TBL] [Abstract][Full Text] [Related]
18. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
[TBL] [Abstract][Full Text] [Related]
19. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Kim YI; Kim HS; Park JW
PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]